Log in to save to my catalogue

Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlle...

Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlle...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3219012

Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials

About this item

Full title

Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2011-06, Vol.15 (3), p.R140-R140, Article R140

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Patients undergoing coronary revascularization often require inotropic support that has been associated with an increased risk for death and morbidity. The purpose of this study was to evaluate the effect of levosimendan versus control on survival after coronary revascularization.
A systemic review and meta-analysis of the literature was carried...

Alternative Titles

Full title

Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3219012

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3219012

Other Identifiers

ISSN

1364-8535

E-ISSN

1364-8535,1466-609X

DOI

10.1186/cc10263

How to access this item